This is the authors' abstract. We don't add key points for this paper.
Pregnancy in patients with sickle cell disease (SCD) carries a high risk of severe maternal and fetal morbidity and mortality. Severe complications include vaso-occlusive crises (VOCs), acute chest syndrome (ACS), preeclampsia, chronic anemia, and severe infections, including sepsis and septic shock. The physiological changes of pregnancy, including increased metabolic demands in the setting of chronic hypoxia, immunocompromise, and vascular crises, are primarily responsible for the increased risk of these complications. These patients are at increased risk of placental pathologies, including placental hypoperfusion and infarction, which increase the risk of abruptio placentae and lower segment cesarean section (LSCS). In addition to the complications associated with these placental abnormalities, fetal growth may be compromised, resulting in intrauterine growth restriction (IUGR), low birth weight, preterm delivery, and stillbirth. Increased awareness of SCD and its complications in these patients, proactive multidisciplinary team management in the intensive therapy setting, frequent monitoring along with appropriate antenatal care, preconception counseling, early cessation of teratogenic medications, folic acid supplementation, and fetal ultrasound surveillance can positively impact pregnancy outcomes. Preventive medications, such as aspirin, should be started at a low dose after 12 weeks of gestation. Prophylactic or therapeutic transfusion in pregnant patients with SCD should be considered selectively or proactively in cases of severe chronic anemia, organ damage, stroke, or recurrent or persistent painful crises. Prompt hydration, safe and adequate analgesia, maintenance of oxygenation, and early detection and aggressive management of severe infection can help prevent further sickling and its complications, thereby improving maternal and fetal outcomes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Amara et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: